Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Influenza

  Free Subscription


18.09.2017

1 Arch Virol
2 Biochem Biophys Res Commun
1 Epidemiol Infect
1 J Gen Virol
2 J Immunol
1 J Infect
2 J Infect Dis
1 J Virol
2 PLoS One
8 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. WOO C, Kwon JH, Lee DH, Kim Y, et al
    Novel reassortant clade 2.3.4.4 avian influenza A (H5N8) virus in a grey heron in South Korea in 2017.
    Arch Virol. 2017 Sep 12. doi: 10.1007/s00705-017-3547.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. KIM YJ, Ko EJ, Kim MC, Lee YN, et al
    Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.
    Biochem Biophys Res Commun. 2017 Sep 5. pii: S0006-291X(17)31771.
    PubMed     Text format     Abstract available

  3. MA JH, Song SH, Guo M, Zhou J, et al
    Long-term exposure to PM2.5 lowers influenza virus resistance via down-regulating pulmonary macrophage Kdm6a and mediates histones modification in IL-6 and IFN-beta promoter regions.
    Biochem Biophys Res Commun. 2017 Sep 5. pii: S0006-291X(17)31772.
    PubMed     Text format     Abstract available


    Epidemiol Infect

  4. REGAN AK, Moore HC, Sullivan SG, DE Klerk N, et al
    Epidemiology of seasonal influenza infection in pregnant women and its impact on birth outcomes.
    Epidemiol Infect. 2017 Sep 11:1-10. doi: 10.1017/S0950268817001972.
    PubMed     Text format     Abstract available


    J Gen Virol

  5. CIMINSKI K, Thamamongood T, Zimmer G, Schwemmle M, et al
    Novel insights into bat influenza A viruses.
    J Gen Virol. 2017 Sep 14. doi: 10.1099/jgv.0.000927.
    PubMed     Text format     Abstract available


    J Immunol

  6. ZHAO Y, Jamaluddin M, Zhang Y, Sun H, et al
    Systematic Analysis of Cell-Type Differences in the Epithelial Secretome Reveals Insights into the Pathogenesis of Respiratory Syncytial Virus-Induced Lower Respiratory Tract Infections.
    J Immunol. 2017;198:3345-3364.
    PubMed     Text format     Abstract available

  7. DE BRUIJN MJ, Rip J, van der Ploeg EK, van Greuningen LW, et al
    Distinct and Overlapping Functions of TEC Kinase and BTK in B Cell Receptor Signaling.
    J Immunol. 2017;198:3058-3068.
    PubMed     Text format     Abstract available


    J Infect

  8. SU W, Cheng KL, Chu DK, Zhou J, et al
    Genetic analysis of H7N9 highly pathogenic avian influenza virus in Guangdong, China, 2016-2017.
    J Infect. 2017 Sep 7. pii: S0163-4453(17)30272.
    PubMed     Text format    


    J Infect Dis

  9. DATTA S, Walsh EE, Peterson DR, Falsey AR, et al
    Can Analysis of Routine Viral Testing Provide Accurate Estimates of Respiratory Syncytial Virus Disease Burden in Adults?
    J Infect Dis. 2017;215:1706-1710.
    PubMed     Text format     Abstract available

  10. MOE N, Stenseng IH, Krokstad S, Christensen A, et al
    The Burden of Human Metapneumovirus and Respiratory Syncytial Virus Infections in Hospitalized Norwegian Children.
    J Infect Dis. 2017;216:110-116.
    PubMed     Text format     Abstract available


    J Virol

  11. KEEF E, Zhang LA, Swigon D, Urbano A, et al
    Discrete dynamical modeling of influenza infection suggests age-dependent differences in immunity.
    J Virol. 2017 Sep 13. pii: JVI.00395-17. doi: 10.1128/JVI.00395.
    PubMed     Text format     Abstract available


    PLoS One

  12. CHROMIKOVA V, Zaragoza MA, Krammer F
    Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody.
    PLoS One. 2017;12:e0183315.
    PubMed     Text format     Abstract available

  13. BOYD M, Baker MG, Mansoor OD, Kvizhinadze G, et al
    Protecting an island nation from extreme pandemic threats: Proof-of-concept around border closure as an intervention.
    PLoS One. 2017;12:e0178732.
    PubMed     Text format     Abstract available


    Vaccine

  14. NEUZIL KM, Bresee JS, de la Hoz F, Johansen K, et al
    Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31188.
    PubMed     Text format     Abstract available

  15. SANTOS JJS, Obadan AO, Garcia SC, Carnaccini S, et al
    Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31157.
    PubMed     Text format     Abstract available

  16. WOO EJ, Moro PL, Cano M, Jankosky C, et al
    Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31135.
    PubMed     Text format     Abstract available

  17. ADAMSON PJ, Al Kindi MA, Wang JJ, Colella AD, et al
    Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31151.
    PubMed     Text format     Abstract available

  18. VICKERS ER, McClure DL, Naleway AL, Jacobsen SJ, et al
    Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31186.
    PubMed     Text format     Abstract available

  19. LUZ PM, Johnson RE, Brown HE
    Workplace availability, risk group and perceived barriers predictive of 2016-17 influenza vaccine uptake in the United States: A cross-sectional study.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31178.
    PubMed     Text format     Abstract available

  20. RAVIOTTA JM, Smith KJ, DePasse J, Brown ST, et al
    Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)30977.
    PubMed     Text format     Abstract available

  21. ISLAM S, Mohn KG, Krammer F, Sanne M, et al
    Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31132.
    PubMed     Text format     Abstract available


    Virology

  22. TAKEMAE N, Tsunekuni R, Sharshov K, Tanikawa T, et al
    Five distinct reassortants of H5N6 highly pathogenic avian influenza A viruses affected Japan during the winter of 2016-2017.
    Virology. 2017;512:8-20.
    PubMed     Text format     Abstract available

  23. WILSON JR, Belser JA, DaSilva J, Guo Z, et al
    An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.
    Virology. 2017;511:214-221.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: